
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Iron protein succinylate is a chelated iron supplement that combines elemental iron with protein and succinic acid to enhance bioavailability. This formulation improves iron absorption by up to 40% compared to traditional ferrous sulfate by protecting iron from gastric degradation.

Reported Benefits (Provisional)
Origin & History

Iron Protein Succinylate is a form of iron bound to a protein, designed to improve absorption and reduce gastrointestinal discomfort.
Research Narrative (Provisional)
Research indicates that Iron Protein Succinylate is effective in treating iron deficiency with a lower incidence of gastrointestinal side effects. Some studies suggest it may be better tolerated than other iron supplements.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
Iron Protein Succinylate (IPS) is a specialty iron compound, not a whole food, so it does not contain macronutrients (carbohydrates, fats) or dietary fiber in meaningful quantities. Key compositional data: Iron content: approximately 10–12% elemental iron by weight, delivered as ferric iron (Fe³⁺) complexed with succinylated casein protein carrier. A standard therapeutic dose of 40 mg IPS provides approximately 4–5 mg elemental iron. The succinylated casein matrix constitutes the majority of the compound's mass (~88–90%) and contributes negligible but trace amounts of protein-derived amino acids (predominantly glutamic acid, aspartic acid, and lysine residues altered by succinylation). Bioavailability notes: The protein-bound ferric iron is released selectively in the intestinal lumen at pH >7 (duodenum and jejunum), bypassing gastric acid exposure, which significantly reduces oxidative irritation to the gastric mucosa. Bioavailability of elemental iron from IPS is estimated at 20–40% relative absorption efficiency, comparable to or exceeding ferrous sulfate in populations with normal and compromised gut function. No co-factors (vitamin C, B12, folate) are inherently present in the compound itself; concurrent dietary intake of ascorbic acid can further enhance iron uptake. No significant levels of other vitamins or minerals are present within the IPS compound itself.
Reported Mechanism (Provisional)
Iron protein succinylate works by chelating iron with protein molecules and succinic acid, protecting the iron from precipitation in alkaline environments. The protein component facilitates transport across intestinal epithelial cells via amino acid transporters, while succinic acid maintains iron solubility. This dual protection mechanism bypasses the typical iron absorption barriers that affect ferrous and ferric salts.
Clinical Narrative (Provisional)
Clinical trials with 200-400 participants have demonstrated 30-40% higher iron absorption rates compared to ferrous sulfate. Studies in pregnant women showed significant improvements in hemoglobin levels with 30mg daily doses over 12 weeks. Comparative trials report 60% fewer gastrointestinal side effects than conventional iron salts. However, most studies are small-scale with 8-16 week durations, limiting long-term safety data.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







